Company Filing History:
1 out of 832,880 Years Active: 2001
Title: The Innovative Contributions of Shawn Barney
Introduction
Shawn Barney is a notable inventor based in Cary, NC (US). He has made significant contributions to the field of anti-retroviral research, particularly through his patented inventions. His work focuses on developing peptides that exhibit potent anti-retroviral activity, which can have a profound impact on public health.
Latest Patents
Shawn Barney holds a patent titled "Compositions for inhibition of membrane fusion-associated events, including human parainfluenza virus transmission." This invention relates to peptides that inhibit the transmission of retroviruses, especially HIV, to uninfected cells. The peptides include DP178, which corresponds to specific amino acids of the HIV-1 gp41 protein, along with its fragments, analogs, and homologs. This innovative approach could lead to new therapeutic strategies in combating viral infections.
Career Highlights
Throughout his career, Shawn Barney has demonstrated a commitment to advancing scientific knowledge and developing practical solutions to complex health issues. His work has not only contributed to the understanding of retroviral transmission but also paved the way for potential treatments that could save lives.
Collaborations
Shawn has collaborated with esteemed colleagues, including Dennis Michael Lambert and Stephen Robert Petteway. These partnerships have enhanced the research and development of his innovative ideas, fostering a collaborative environment that encourages scientific discovery.
Conclusion
Shawn Barney's contributions to the field of anti-retroviral research exemplify the impact of innovation in healthcare. His patented work on peptides for inhibiting viral transmission showcases the potential for scientific advancements to address critical health challenges.